Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Raised to $91 at Baird

July 14, 2026 6:25 AM
Baird analyst David Rescott raised the price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $85.00) while maintaining a Neutral rating.

Categories

Analyst PT Change